Genmab revenue increased 21% compared to the first nine months of 2024, to $2,662 million FDA granted BTD to Rina-S ® in advanced endometrial cancer Epcoritamab Phase 3 EPCORE ® FL-1 trial met dual ...

Discover Otter Tail Corp's Q3 2025 earnings call insights—capital growth, updated EPS guidance, and strong utility outlook.

November 6, 2025 Copenhagen, Denmark; Interim Report for the Nine Months Ended September 30, 2025 Highlights Announcement of Genmab's proposed acquisition of Merus N.V. (Merus)Genmab revenue increased ...

Viridian Therapeutics, Inc. nears profitability and gears up for veligrotug’s 2025 launch. Click here to find out why VRDN stock is a Strong Buy.

John Cena will appear for the final time in Boston on a stacked edition of WWE Raw. What will the 17-time world champion say ...

Otter Tail Corporation (NASDAQ: OTTR) Q3 2025 Earnings Call Transcript November 4, 2025 Operator: Good morning, and welcome ...

On Saturday night, the New Orleans Pelicans take on Victor Wembanyama and the San Antonio Spurs in a thrilling NBA matchup.

The Packers are 1-4 against the Eagles in LaFleur's tenure. It's time to start turning that around. I don't know if this is the right place to mention this, but last week I ordered a giant box of FULL ...

Announced positive results from two pivotal Phase 3 Essential3 studies of ulixacaltamide HCl in essential tremor (ET); Pre-NDA meeting with FDA ...

Zai Lab Limited today announced financial results for the third quarter of 2025, along with recent product highlights and corporate updates. "Zai Lab is entering the next phase of our growth, powered ...

Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.

Granted FDA Breakthrough Therapy Designation for ficerafusp alfa in combination with pembrolizumab in 1L HPV-negative R/M HNSCCData from a Phase ...